Breast cancer is a global health issue affecting 2.3 million women per year, causing death in over 600,000. Mammography (and biopsy) is the gold standard for screening and diagnosis. Whilst effective, this test exposes individuals to radiation, has limit
Diagnostic performance of digital vs film mammography for breast-cancer screening. N Engl J Med. 2005;353(17):1773-1783.PubMedGoogle ScholarCrossref 5. Rafferty EA, Park JM, Philpotts LE, et al. Assessing radiologist performance using combined digital mammography and breast tomosynthesis compared...
The restart of the screening program and the increased hospital capacity for non-COVID care led to an increase in breast cancer diagnoses (Dinmohamed et al., 2020a). However, the effect of the suspension of the screening program on the incidence of screen-detected breast tumors, as well as...
There are many active or recently completed breast cancer screening and treatment trials in 2023 that have the potential to fundamentally change the way breast radiologists practice medicine. Breast cancer screening trials may provide evidence to support supplemental screening beyond mammography to include ...
USPSTF Recommendation: Screening for Breast Cancer 14 min 15 sec What's New? The USPSTF now recommends screening mammography for women aged 40 to 49 years every 2 years, rather than individualizing the decision in this age group. Other parts of the new recommendation are similar to the 2016...
This is our second in the series, and updates our Breast Cancer Awareness Month 2022 post from last year. For Breast Cancer Month 2023, we will be looking at all of the new guidelines, therapies and innovations on breast cancer screenings and treatment that have been introduced since Breast ...
Rebecca A. Hubbard, in Breast Cancer Screening, 2016 Abstract Breast cancer screening aims to reduce mortality, but the screening process introduces harm as well as benefit. Over the past several decades, mammographic breast cancer screening has been the subject of controversy with questions focusing...
Comparison of AI-integrated pathways with human-AI interaction in population mammographic screening for breast cancer Successful human-AI collaboration could greatly contribute to breast cancer mammographic screening. Here, the authors use a large-scale retrospective mammography dataset to simulate and compare...
In December 2022, the Council of the European Union adopted a new approach to cancer screening. This new EU approach, based on the latest available scientific developments and evidence, will help ensure that 90% of the EU population who qualify
This guideline updates the American Cancer Society breast cancer screening recommendations for women at average risk for breast cancer.